MedPath

EFFECTIVENESS OF MOBILE APPLICATION(EASYDM) FOR DIABETES CONTROL FOCUSING ON DIABETES MEDICATION ADHERENCE AMONG UNCONTROLLED DIABETES PATIENTS ATTENDING PRIMARY CARE UNITS IN BANGKOK THAILAND : RANDOMIZED CONTROLLED TRIA

Phase 2
Completed
Conditions
ncontrolled diabetes may result from several factors including medication not adhered by patients. Medication adherence plays important role in optimizing glycemic level which delays diabetic complic
mobile application&#44
medication adherence&#44
diabetes&#44
primary health care&#44
Thailand
Registration Number
TCTR20190509002
Lead Sponsor
THE 90 TH Anniversary of Chulalongkorn University Scholarship
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
186
Inclusion Criteria

Inclusion criteria are-
Diagnosed type 2 diabetics both sexes
Age between 45-65 years (Papier et al., 2016)
HbA1C level > 7% at last assessment within 3 months (Castensøe-Seidenfaden et al., 2018)
Morisky Medication Adherence Score less than 6 (Butt et al., 2016)
Diabetes patients with same number of main medications on (e.g. Metformin, others, etc)
Having smart phones with Android/iOS software compatible with (EASYDM) apps (Ristau, Yang, & White, 2013)
Offering consent and agreed to participate

Exclusion Criteria

Exclusion criteria are-
Severe cardiac, renal functions, hepatic, cognitive or psychological impairments (Bergenstal et al., 2019)
Those on current insulin injection

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Diabetes medication Adherence 1. Medication Adherence Scores 2. Number of pills 3 months Descriptive statistics for baseline characteristics will be used (t-tests, chi square tests). Intent
Secondary Outcome Measures
NameTimeMethod
HbA1C before and after intervention within 3 months HbA1C level will be the secondary outcome (Clifford et al., 2014) which will be Expressed in percen
© Copyright 2025. All Rights Reserved by MedPath